Skip to main content
. 2022 Mar 21;11(3):170–185. doi: 10.4103/EUS-D-21-00044

Figure 1.

Figure 1

Forest plot showing pooled rates of clinical success (a) and technical success (b) after EUS–radiofrequency ablation and EUS-EA of pancreatic neuroendocrine tumors